Pancreatic Insulin Production Capacity (PIPC) - a Feasibility Study
About this study
The standard treatment for Type 2 diabetes involves management of the disease based on average of blood glucose control over the past few months. In this study, the investigators test for the participants' ability to produce insulin, which is the hormone that the body makes to control blood sugar levels. The body produces insulin in response to eating. The participants will drink a meal replacement shake, and then test the blood for levels of insulin produced over 2 hours. With blood tests taken five times over two hours, the investigators will measure the blood glucose (sugar), and insulin levels. This study will assess the differences in insulin produced in the participants and try to understand the reasons for these differences.
- Condition
- Type 2 Diabetes
- Tested
- Boost Original meal replacement shake
- Sponsor
- Ottawa Hospital Research Institute
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 18 years
- Study condition: Type 2 Diabetes
- Consent provided
- Age \>= 18 years.
- Diagnosed as type 2 diabetes mellitus.
- Not on insulin therapy.
Exclusion 3
- Diagnosed as another form of diabetes mellitus.
- Allergic to one or more ingredients in Boost meal replacement shake.
- Unable to fast since midnight and attend in person for the morning protocol.
Where
1 site, 1 recruiting
The Ottawa Hospital
Ottawa, Ontario, Canada
Contact
-
Cathy Sun, MD MSc
613-738-8333 csun@toh.ca
Potential match only. Final eligibility is determined by the study team.